Ascend Wellness Holdings, Inc. 8K

Ascend Wellness Holdings, Inc. announced solid Q2 2026 revenue and cash flow growth, expanded its retail footprint, advanced a reverse stock split and uplisting plan, pursued DEA registration, and resolved a labor stoppage that may affect Q3 performance.

Ascend Wellness Holdings, Inc. reported its second quarter 2026 results, highlighting net revenue of $126.1 million, adjusted EBITDA of $29.1 million and improved cash generation, alongside continued retail expansion to 55 locations, a roughly 5% combined market share gain across its seven markets, accelerated product innovation and loyalty engagement, and the filing of a definitive proxy statement to seek shareholder approval on August 28, 2026 for a reverse stock split to support a planned uplisting to a major U.S. exchange. The company also submitted DEA registration applications for certain medical cannabis operations under the expedited Schedule III pathway and disclosed that it resolved a June–August 2026 work stoppage at its Barry, Illinois facility under a new contract, noting limited Q2 impact but potential implications for Q3 results.

Filing Facts

CIK

1756390

Ticker

-

Form

8K

Source Type

sec

Accession

0001628280-26-056190

Alert Tier

7